APA (7th ed.) Citation

Wang, Y., Jiang, C., Zhou, H., & Han, R. (2025). Transforming cancer immunotherapy: Integration of distinct immune-based approaches as redefined dual immunotherapy with potential third-sensitizer. Experimental Hematology & Oncology, 14(1), 1. https://doi.org/10.1186/s40164-025-00705-9

Chicago Style (17th ed.) Citation

Wang, Yuqian, Cheng Jiang, Huiling Zhou, and Rui Han. "Transforming Cancer Immunotherapy: Integration of Distinct Immune-based Approaches as Redefined Dual Immunotherapy with Potential Third-sensitizer." Experimental Hematology & Oncology 14, no. 1 (2025): 1. https://doi.org/10.1186/s40164-025-00705-9.

MLA (9th ed.) Citation

Wang, Yuqian, et al. "Transforming Cancer Immunotherapy: Integration of Distinct Immune-based Approaches as Redefined Dual Immunotherapy with Potential Third-sensitizer." Experimental Hematology & Oncology, vol. 14, no. 1, 2025, p. 1, https://doi.org/10.1186/s40164-025-00705-9.